Assignee
INNOSIGN B V
NL·4 granted patents·11 pending applications·3 citations·filing 2016–2023
Top patents by PatentIndex Score
15 records- 0172US11450409B2Determination of NFkB pathway activity using unique combination of target genesINNOSIGN B V·Filed 2016·Granted Sep 20, 2022·1 cites·21 claims
- 0269US2023030858A1Assessment of cellular signaling pathway activity using linear combination(s) of target gene expressionsINNOSIGN B V·Filed 2022·Application pending·0 cites
- 0369US2023260595A1Determination of nfkb pathway activity using unique combination of target genesINNOSIGN B V·Filed 2022·Application pending·0 cites
- 0468US2023105263A1Assessment of cellular signaling pathway activity using probabilistic modeling of target gene expressionINNOSIGN B V·Filed 2022·Application pending·0 cites
- 0564US11649488B2Determination of JAK-STAT1/2 pathway activity using unique combination of target genesINNOSIGN B V·Filed 2018·Granted May 16, 2023·2 cites·8 claims
- 0655US2023111281A1Identification of the cellular function of an active nfkb pathwayINNOSIGN B V·Filed 2020·Application pending·0 cites
- 0753US2024052415A1Comparison and standardization of cell and tissue cultureINNOSIGN B V·Filed 2022·Application pending·0 cites
- 0852US2026062755A1Prediction and monitoring of immunotherapy in cancerINNOSIGN B V·Filed 2023·Application pending·0 cites
- 0950US2024043930A1Treatment prediction and effectiveness of anti-tnf alpha treatment in ibd patientsINNOSIGN B V·Filed 2021·Application pending·0 cites
- 1047US2023223108A1Prognostic pathways for viral infectionsINNOSIGN B V·Filed 2021·Application pending·0 cites
- 1147US2023098637A1Prognostic pathways for high risk sepsis patientsINNOSIGN B V·Filed 2021·Application pending·0 cites
- 1246US2023071390A1Assessment of pr cellular signaling pathway activity using mathematical modelling of target gene expressionINNOSIGN B V·Filed 2020·Application pending·0 cites
- 1346US2023416820A1Pcr method and kit for determining pathway activityINNOSIGN B V·Filed 2021·Application pending·0 cites
- 1440US12125561B2Determination of JAK-STAT3 pathway activity using unique combination of target genesINNOSIGN B V·Filed 2018·Granted Oct 22, 2024·0 cites·5 claims
- 1538US11776661B2Determination of MAPK-AP-1 pathway activity using unique combination of target genesINNOSIGN B V·Filed 2018·Granted Oct 3, 2023·0 cites·10 claims
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →